The Valley Desk

Healthcare research from Johnson & Johnson, page 27

A filtered view. Show the full list.

Refine

817 publications and 7 software projects · listings 625–648

Listings

  1. ArticleNature communications

    The role of cytochrome bc1 inhibitors in future tuberculosis treatment regimens

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Clinical careAdded

  2. ArticleSchizophrenia (Heidelberg, Germany)

    Data analysis strategies for the Accelerating Medicines Partnership® Schizophrenia Program

    Verified Author affiliations on the Europe PMC record name Johnson & Johnson, Perelman School of Medicine, University of Pennsylvania. Affiliation source

    Research dataAdded

  3. ArticleNature chemistry

    Accessing sulfonamides via formal SO2 insertion into C-N bonds

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Biomedical and life sciencesAdded

  4. ArticleNature

    Strategic atom replacement enables regiocontrol in pyrazole alkylation

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Other scienceAdded

  5. ArticleNature biotechnology

    Folding-mediated secretion of pure bispecific antibodies

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Biomedical and life sciencesAdded

  6. Clinical trial reportNature medicine

    Daratumumab plus bortezomib, lenalidomide and dexamethasone for transplant-ineligible or transplant-deferred newly diagnosed multiple myeloma: the randomized phase 3 CEPHEUS trial

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Clinical careAdded

  7. ArticleNature medicine

    The Global Neurodegeneration Proteomics Consortium: biomarker and drug target discovery for common neurodegenerative diseases and aging

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Research dataAdded

  8. Clinical trial reportNature medicine

    Niraparib and abiraterone acetate plus prednisone for HRR-deficient metastatic castration-sensitive prostate cancer: a randomized phase 3 trial

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Clinical careAdded

  9. ArticleScientific reports

    A novel label-free method to determine equilibrium dissociation constants of antibodies binding to cell surface proteins

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Biomedical and life sciencesAdded

  10. ArticleScientific reports

    Prediction of treatment-resistant depression using the 23andMe survey data

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Disease researchAdded

  11. ArticleNPJ digital medicine

    Standardized patient profile review using large language models for case adjudication in observational research

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Clinical careAdded

  12. ArticleNPJ digital medicine

    A systematic review of digital and imaging technologies for measuring fatigue in immune mediated inflammatory diseases

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Disease researchAdded

  13. ArticleNPJ digital medicine

    Unlocking efficiency in real-world collaborative studies: a multi-site international study with one-shot lossless GLMM algorithm

    Verified Author affiliations on the Europe PMC record name Johnson & Johnson, Perelman School of Medicine, University of Pennsylvania. Affiliation source

    Research dataAdded

  14. ArticleCommunications biology

    Unveiling inverted D genes and D-D fusions in human antibody repertoires unlocks novel antibody diversity

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Biomedical and life sciencesAdded

  15. ArticleCommunications biology

    Genetic background and oncogenic driver determines the genomic evolution and transcriptomics of mammary tumor metastasis

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Disease researchAdded

  16. Clinical trial reportGastroenterology

    Efficacy and Safety of Guselkumab Subcutaneous Induction and Maintenance in Participants With Moderately to Severely Active Crohn's Disease: Results From the Phase 3 GRAVITI Study

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Clinical careAdded

  17. ReviewGastroenterology

    Artificial Intelligence-Enabled Clinical Trials in Inflammatory Bowel Disease: Automating and Enhancing Disease Assessment and Study Management

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Research dataAdded

  18. Clinical trial reportAmerican journal of perinatology

    Design of a Phase 3, Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of Nipocalimab in Pregnancies at Risk for Fetal and Neonatal Alloimmune Thrombocytopenia

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Clinical careAdded

  19. Clinical trial reportAmerican journal of perinatology

    Design of a Phase 3, Multicenter, Randomized, Open-Label Study of Nipocalimab or IVIG and Prednisone in Pregnancies at Risk for Fetal and Neonatal Alloimmune Thrombocytopenia

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Research dataAdded

  20. Clinical trial reportNEJM evidence

    Targeted Oral Peptide Icotrokinra for Psoriasis Involving High-Impact Sites

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Clinical careAdded

  21. Case reportThe New England journal of medicine

    CAR+ T-Cell Lymphoma after Cilta-cel Therapy for Relapsed or Refractory Myeloma

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Clinical careAdded

  22. Clinical trial reportThe New England journal of medicine

    Daily Mosnodenvir as Dengue Prophylaxis in a Controlled Human Infection Model

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Clinical careAdded

  23. Clinical trial reportThe New England journal of medicine

    Overall Survival with Amivantamab-Lazertinib in EGFR-Mutated Advanced NSCLC

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Clinical careAdded

  24. Clinical trial reportThe New England journal of medicine

    Oral Icotrokinra for Plaque Psoriasis in Adults and Adolescents

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Clinical careAdded